BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gatti M, Raschi E, Moretti U, Ardizzoni A, Poluzzi E, Diemberger I. Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase. Vaccines (Basel) 2021;9:19. [PMID: 33406694 DOI: 10.3390/vaccines9010019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Lopez-olivo MA, Valerio V, Karpes Matusevich AR, Brizio M, Kwok M, Geng Y, Suarez-almazor ME, Colmegna I. Safety and Efficacy of Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitors. Systematic Review with Meta-Analysis. Vaccines 2022;10:1195. [DOI: 10.3390/vaccines10081195] [Reference Citation Analysis]
2 Flora J, Khan W, Jin J, Jin D, Hussain A, Dajani K, Khan B. Usefulness of Vaccine Adverse Event Reporting System for Machine-Learning Based Vaccine Research: A Case Study for COVID-19 Vaccines. Int J Mol Sci 2022;23:8235. [PMID: 35897804 DOI: 10.3390/ijms23158235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Fadah K, Abolbashari M, Ojha C, Alkhateeb H. Acute Myopericarditis After First Dose of mRNA-1273 SARS-CoV-2 Vaccine in a Young Adult. Cureus 2022. [DOI: 10.7759/cureus.22111] [Reference Citation Analysis]
4 Chouchana L, Blet A, Al-Khalaf M, Kafil TS, Nair G, Robblee J, Drici MD, Valnet-Rabier MB, Micallef J, Salvo F, Treluyer JM, Liu PP. Features of Inflammatory Heart Reactions Following mRNA COVID-19 Vaccination at a Global Level. Clin Pharmacol Ther 2021. [PMID: 34860360 DOI: 10.1002/cpt.2499] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
5 Chachar TS, Yousuf N, Sulaibikh L, Abdulqader F, Alqahtani M. First Report of Acute Myocarditis Post-Pfizer-BioNTech COVID-19 Vaccination in the Kingdom of Bahrain. Cureus 2021;13:e20313. [PMID: 35028213 DOI: 10.7759/cureus.20313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wijesundara DK, Williams C, Sun W, Furuya AM, Furuya Y. Fear of Influenza Resurgence amid COVID-19 Pandemic: Need for Effective Flu Vaccine Still Exists. Vaccines (Basel) 2021;9:1198. [PMID: 34696304 DOI: 10.3390/vaccines9101198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Chouchana L, Blet A, Al-khalaf M, Kafil TS, Nair G, Robblee J, Drici M, Valnet-rabier M, Micallef J, Salvo F, Treluyer J, Liu PP. Cardiac Inflammation after COVID-19 mRNA Vaccines: A Global Pharmacovigilance Analysis.. [DOI: 10.1101/2021.08.12.21261955] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Gatti M, Turrini E, Raschi E, Sestili P, Fimognari C. Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues. Pharmaceuticals (Basel) 2021;14:738. [PMID: 34451835 DOI: 10.3390/ph14080738] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
9 Multiple drugs. Reactions Weekly 2021;1853:344-344. [DOI: 10.1007/s40278-021-95210-5] [Reference Citation Analysis]